Antibody-mimetic drug conjugate with efficient internalization activity using anti-HER2 VHH and duocarmycin
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Antibody-mimetic drug conjugate with efficient internalization activity using anti-HER2 VHH and duocarmycin
Authors
Keywords
-
Journal
PROTEIN EXPRESSION AND PURIFICATION
Volume -, Issue -, Pages 106375
Publisher
Elsevier BV
Online
2023-10-04
DOI
10.1016/j.pep.2023.106375
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pathological complete remission of relapsed tumor by photo‐activating antibody–mimetic drug conjugate treatment
- (2022) Yudai Kaneko et al. CANCER SCIENCE
- Novel small 99mTc-labeled affibody molecular probe for PD-L1 receptor imaging
- (2022) Zhigang Liang et al. Frontiers in Oncology
- Duocarmycin-based antibody–drug conjugates as an emerging biotherapeutic entity for targeted cancer therapy: Pharmaceutical strategy and clinical progress
- (2021) Hang-Ping Yao et al. DRUG DISCOVERY TODAY
- Nanobodies as efficient drug-carriers: Progress and trends in chemotherapy
- (2021) Sandeep Surendra Panikar et al. JOURNAL OF CONTROLLED RELEASE
- Biochemistry, structure, and cellular internalization of a four nanobody‐bearing Fc dimer
- (2021) Eric Chabrol et al. PROTEIN SCIENCE
- Antibody mimetic drug conjugate manufactured by high-yield Escherichia coli expression and non-covalent binding system
- (2021) Kenzo Yamatsugu et al. PROTEIN EXPRESSION AND PURIFICATION
- TGFβ receptor endocytosis and Smad signaling require synaptojanin1−, PI3K-C2α−, and INPP4B−mediated phosphoinositide conversions
- (2020) Sho Aki et al. MOLECULAR BIOLOGY OF THE CELL
- Safety and Tolerability of Antibody-Drug Conjugates in Cancer
- (2019) Anna Wolska-Washer et al. DRUG SAFETY
- Analysis of Endocytic Uptake and Retrograde Transport to the Trans-Golgi Network Using Functionalized Nanobodies in Cultured Cells
- (2019) Dominik P. Buser et al. Jove-Journal of Visualized Experiments
- Nanobody: outstanding features for diagnostic and therapeutic applications
- (2019) J.-Pablo Salvador et al. ANALYTICAL AND BIOANALYTICAL CHEMISTRY
- Total Synthesis of (+)-CC-1065 Utilizing Ring Expansion Reaction of Benzocyclobutenone Oxime Sulfonate
- (2019) Taku Imaizumi et al. ORGANIC LETTERS
- Novel HER2-Targeting Antibody-Drug Conjugates of Trastuzumab Beyond T-DM1 in Breast Cancer: Trastuzumab Deruxtecan(DS-8201a) and (Vic-)Trastuzumab Duocarmazine (SYD985)
- (2019) Zhuyu Xu et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Cupid and Psyche system for the diagnosis and treatment of advanced cancer
- (2019) Akira SUGIYAMA et al. PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES
- Variable Heavy Chain Domain Derived from a Cell-Penetrating Anti-DNA Monoclonal Antibody for the Intracellular Delivery of Biomolecules
- (2017) Sun-Woo Im et al. IMMUNOLOGICAL INVESTIGATIONS
- SYD985, a Novel Duocarmycin-Based HER2-Targeting Antibody-Drug Conjugate, Shows Antitumor Activity in Uterine Serous Carcinoma with HER2/Neu Expression
- (2016) J. Black et al. MOLECULAR CANCER THERAPEUTICS
- Affibody-mediated PET imaging of HER3 expression in malignant tumours
- (2015) Maria Rosestedt et al. Scientific Reports
- Affibody molecules: Engineered proteins for therapeutic, diagnostic and biotechnological applications
- (2010) J. Löfblom et al. FEBS LETTERS
- Yatakemycin: total synthesis, DNA alkylation, and biological properties
- (2007) Mark S. Tichenor et al. NATURAL PRODUCT REPORTS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started